Simulations Plus (SLP) to Release Earnings on Thursday

Simulations Plus (NASDAQ:SLP) will likely be announcing its Q2 2026 results before the market opens on Thursday, April 2nd. Analysts expect the company to announce earnings of $0.27 per share and revenue of $21.6590 million for the quarter. Investors may review the information on the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Thursday, April 2, 2026 at 5:00 PM ET.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings results on Thursday, January 8th. The technology company reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.05). The company had revenue of $18.42 million during the quarter, compared to the consensus estimate of $18.05 million. Simulations Plus had a negative net margin of 81.66% and a positive return on equity of 14.02%. During the same quarter in the prior year, the business earned $0.17 earnings per share. On average, analysts expect Simulations Plus to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Simulations Plus Stock Down 0.3%

NASDAQ:SLP opened at $11.54 on Thursday. Simulations Plus has a twelve month low of $11.16 and a twelve month high of $36.45. The firm has a market capitalization of $232.50 million, a price-to-earnings ratio of -3.61 and a beta of 1.17. The stock’s 50 day moving average price is $14.27 and its two-hundred day moving average price is $16.20.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on SLP. TD Cowen restated a “hold” rating on shares of Simulations Plus in a report on Thursday, January 8th. BTIG Research cut shares of Simulations Plus from a “buy” rating to a “neutral” rating in a research note on Thursday, December 18th. Zacks Research downgraded shares of Simulations Plus from a “strong-buy” rating to a “hold” rating in a research report on Monday, February 2nd. Wall Street Zen upgraded shares of Simulations Plus from a “hold” rating to a “buy” rating in a research note on Saturday, March 21st. Finally, Citigroup reaffirmed a “market perform” rating on shares of Simulations Plus in a report on Tuesday, January 6th. Three research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $25.00.

Institutional Trading of Simulations Plus

Hedge funds have recently modified their holdings of the stock. Raymond James Financial Inc. bought a new stake in shares of Simulations Plus during the 2nd quarter worth about $25,000. Quarry LP acquired a new stake in Simulations Plus during the third quarter worth approximately $28,000. US Bancorp DE boosted its holdings in shares of Simulations Plus by 32.5% during the third quarter. US Bancorp DE now owns 6,167 shares of the technology company’s stock worth $93,000 after acquiring an additional 1,513 shares during the period. PharVision Advisers LLC bought a new stake in shares of Simulations Plus during the third quarter worth approximately $155,000. Finally, First Trust Advisors LP acquired a new position in shares of Simulations Plus in the third quarter valued at approximately $167,000. Institutional investors and hedge funds own 78.08% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.